Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Vitreous Hemorrhage

• Pre-operative Vabysmo in Patients With Non-clearing Vitreous Hemorrhage Secondary to Proliferative Diabetic Retinopathy
• Cryoapplication Versus Anti-VEGF Before Diabetic Vitrectomy
• A Prospective Study of Ranibizumab in the Treatment of Postoperative Recurrent Vitreous Haemorrhage of Diabetic Retinopathy
• Oral Sedation in Vitreoretinal Surgery
• Intravitreal Aflibercept Injection or Early Vitrectomy for Diabetic Vitreous Hemorrhage
• Endolaserless Vitrectomy With Intravitreal IAI for PDR-Related VH
• Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
• Conbercept Injection in Treatment of Severe Proliferative Diabetic Retinopathy
• Different Hemostasis According to the Anesthetic Agents
• Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic Retinopathy
• Use of Intravitreal Ranibizumab in the Treatment of Vitreous Hemorrhage
• Aflibercept Injection for Proliferative Diabetic Retinopathy
• Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
• A Study of the Safety, Tolerability, and Efficacy of IVT Pre-op 0.3mg Pegaptanib Sodium Versus Sham, for Management of Tractional Retinal Detachment and Vitreous Hemorrhage With Proliferative Diabetic Retinopathy
• Intravitreal Ozurdex After Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy
• Adjuvant Intravitreal Bevacizumab in Pars Plana Vitrectomy for Vitreous Hemorrhage
• Preoperative Intravitreal Ranibizumab for Persistent Diabetic Vitreous Haemorrhage:
• Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N)
• Pre- and Intra-operative Intravitreal Bevacizumab Injection in Diabetic Vitrectomy
• Preoperative Bevacizumab for Vitreous Hemorrhage
• Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage
• Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage